2.28
price down icon2.56%   -0.06
 
loading

Zura Bio Ltd Borsa (ZURA) Ultime notizie

pulisher
Dec 18, 2024

17,442 Shares in Zura Bio Limited (NASDAQ:ZURA) Acquired by The Manufacturers Life Insurance Company - Defense World

Dec 18, 2024
pulisher
Dec 14, 2024

Zura Bio FY2025 EPS Forecast Increased by Leerink Partnrs - Defense World

Dec 14, 2024
pulisher
Dec 13, 2024

Zura Bio FY2025 EPS Forecast Boosted by Leerink Partnrs - MarketBeat

Dec 13, 2024
pulisher
Dec 03, 2024

Zura Bio Limited (NASDAQ:ZURA) Receives $15.80 Average PT from Analysts - Defense World

Dec 03, 2024
pulisher
Nov 30, 2024

Zura Bio Limited (NASDAQ:ZURA) Receives $15.80 Average Target Price from Analysts - MarketBeat

Nov 30, 2024
pulisher
Nov 28, 2024

Zura Bio Limited (NASDAQ:ZURA) Short Interest Update - Defense World

Nov 28, 2024
pulisher
Nov 25, 2024

Zura Bio : to Present at the Piper Sandler 36th Annual Healthcare Conference Form 8 K - Marketscreener.com

Nov 25, 2024
pulisher
Nov 25, 2024

Zura Bio to Present at the Piper Sandler 36th Annual Healthcare Conference - Yahoo Finance

Nov 25, 2024
pulisher
Nov 22, 2024

We're Hopeful That Zura Bio (NASDAQ:ZURA) Will Use Its Cash Wisely - Simply Wall St

Nov 22, 2024
pulisher
Nov 18, 2024

HC Wainwright Reaffirms "Neutral" Rating for Zura Bio (NASDAQ:ZURA) - MarketBeat

Nov 18, 2024
pulisher
Nov 15, 2024

GREAT POINT PARTNERS LLC Reduces Stake in Zura Bio Ltd - GuruFocus.com

Nov 15, 2024
pulisher
Nov 15, 2024

ADAR1 Capital Management, LLC Acquires New Stake in Zura Bio Ltd - GuruFocus.com

Nov 15, 2024
pulisher
Nov 14, 2024

Zura Bio advances Phase 2 study for systemic sclerosis treatment - Investing.com

Nov 14, 2024
pulisher
Nov 14, 2024

Zura Bio Announces Submission of Protocol to U.S. Food and Drug Administration for the Phase 2 Study of Tibulizumab in Adults with Systemic Sclerosis - Yahoo Finance

Nov 14, 2024
pulisher
Nov 13, 2024

HC Wainwright Has Positive Outlook for Zura Bio Q3 Earnings - MarketBeat

Nov 13, 2024
pulisher
Nov 09, 2024

Guggenheim maintains Buy on Zura Bio, target steady at $15 - Investing.com India

Nov 09, 2024
pulisher
Nov 08, 2024

Guggenheim maintains Buy on Zura Bio, target steady at $15 By Investing.com - Investing.com UK

Nov 08, 2024
pulisher
Nov 07, 2024

Zura Bio Reports Third Quarter 2024 Financial Results and Recent Corporate Updates - BioSpace

Nov 07, 2024
pulisher
Nov 06, 2024

Q3 Earnings Forecast for Zura Bio Issued By Leerink Partnrs - MarketBeat

Nov 06, 2024
pulisher
Nov 06, 2024

Zura Bio (NASDAQ:ZURA) Stock Rating Upgraded by Leerink Partnrs - Defense World

Nov 06, 2024
pulisher
Nov 05, 2024

Piper Sandler sets price target on Zura Bio shares, cites positive trial data - Investing.com

Nov 05, 2024
pulisher
Nov 05, 2024

Leerink Partners initiates Zura Bio stock with Outperform rating, $15 target - Investing.com

Nov 05, 2024
pulisher
Oct 30, 2024

Zura Bio Ltd re-elects board, ratifies auditor at AGM By Investing.com - Investing.com Australia

Oct 30, 2024
pulisher
Oct 30, 2024

Zura Bio to Participate in Two Upcoming Investor Conferences in November - Yahoo Finance

Oct 30, 2024
pulisher
Oct 29, 2024

Zura Bio Ltd re-elects board, ratifies auditor at AGM - Investing.com India

Oct 29, 2024
pulisher
Oct 18, 2024

Zura Bio announces departure of Chief Scientific Officer By Investing.com - Investing.com Australia

Oct 18, 2024
pulisher
Oct 18, 2024

Zura Bio announces departure of Chief Scientific Officer - Investing.com India

Oct 18, 2024
pulisher
Oct 17, 2024

Private equity firms among Zura Bio Limited's (NASDAQ:ZURA) largest shareholders, saw gain in holdings value after stock jumped 14% last week - Simply Wall St

Oct 17, 2024
pulisher
Sep 29, 2024

Forefront Analytics LLC Has $145,000 Holdings in Zura Bio Limited (NASDAQ:ZURA) - Defense World

Sep 29, 2024
pulisher
Sep 25, 2024

Zura Bio Limited (NASDAQ:ZURA) Shares Sold by Affinity Asset Advisors LLC - Defense World

Sep 25, 2024
pulisher
Sep 24, 2024

Should investors be concerned about Zura Bio Ltd (ZURA)? - US Post News

Sep 24, 2024
pulisher
Sep 20, 2024

A stock that deserves closer examination: Zura Bio Ltd (ZURA) - US Post News

Sep 20, 2024
pulisher
Sep 20, 2024

Institutions profited after Zura Bio Limited's (NASDAQ:ZURA) market cap rose US$45m last week but private equity firms profited the most - Yahoo Finance

Sep 20, 2024
pulisher
Sep 20, 2024

Piper Sandler maintains Overweight rating on Zura Bio shares - Investing.com

Sep 20, 2024
pulisher
Sep 19, 2024

Zura Bio Ltd [ZURA] Director makes an insider sale of 3,800,000 shares worth 10,260,000. - Knox Daily

Sep 19, 2024
pulisher
Sep 19, 2024

Piper Sandler maintains Overweight rating on Zura Bio shares By Investing.com - Investing.com Australia

Sep 19, 2024
pulisher
Sep 19, 2024

Zura Bio Ltd (ZURA) Stock: Uncovering a 52-Week Range and Trading Volume - The InvestChronicle

Sep 19, 2024
pulisher
Sep 18, 2024

Zura Bio (NASDAQ:ZURA) versus Aligos Therapeutics (NASDAQ:ALGS) Critical Comparison - Defense World

Sep 18, 2024
pulisher
Sep 11, 2024

A Guide To The Risks Of Investing In Zura Bio Ltd (ZURA) - Knox Daily

Sep 11, 2024
pulisher
Sep 09, 2024

Have Zura Bio Insiders Been Selling Stock? - Simply Wall St

Sep 09, 2024
pulisher
Sep 06, 2024

Zura Bio director Sidhu Someit sells shares worth over $200,000 - Investing.com

Sep 06, 2024
pulisher
Sep 05, 2024

Taking a look at what insiders are doing to gauge the Zura Bio Ltd (ZURA)’s direction - Knox Daily

Sep 05, 2024
pulisher
Sep 03, 2024

Zura Bio to Present at Three Upcoming Investor Conferences in September - Yahoo Finance

Sep 03, 2024
pulisher
Sep 02, 2024

Zura Bio Ltd [ZURA] Stock bought by Insider Ploos van Amstel Arnout for $0.5 million - Knox Daily

Sep 02, 2024
pulisher
Sep 02, 2024

Get in on Zura Bio Ltd’s (ZURA) buy-in window today! - SETE News

Sep 02, 2024
pulisher
Aug 27, 2024

Zura Bio Ltd (ZURA) Stock: A Comprehensive 52-Week Review - The InvestChronicle

Aug 27, 2024
pulisher
Aug 21, 2024

Zura Bio issues warrants after share surrender - Investing.com India

Aug 21, 2024
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
Capitalizzazione:     |  Volume (24 ore):